AIM: To explore the effect of
sitagliptin (SLT) on
cardiomyocyte pyroptosis induced by type 2 dia-betes mellitus (T2DM) and the underlying mechanism.
METHODS: The T2DM
rat model was established by
high-fat diet and
intraperitoneal injection of
streptozotocin (35 mg/kg). The model
rats were treated with SLT at 3, 10 and 30 mg/kg and
nicotinamide [NAM; an non-specific inhibitor of
sirtuin (
SIRT )
family ] at 500 mg/kg for 4 weeks.
Fasting blood glu-cose was measured, and the
tissue proteins were determined by the
methods of
Western blot and
immunochemistry . RE-SULTSCompared with
control group , the
pyroptosis of
cardiomyocytes and NLRP3 expression were significantly induced, while the
protein level of
SIRT3 was downregulated by T2DM (P<0.05). SLT inhibited the pyrpotosis of diabetic
rat car -diomyocytes, downregulated the expression of NLRP3, and upregulated the expression of
SIRT3 in a
dose -dependent man-ner (P<0.05). All the function of SLT (30 mg/kg) was reversed by the
treatment with NAM (500 mg/kg). Compared with
control group , the
pyroptosis of
cardiomyocytes and NLRP3 expression were significantly induced, while the
protein level of
SIRT3 was not regulated by NAM (500 mg/kg).
CONCLUSION: SLT exerts the inhibitory effect on the pyropto-sis of
cardiomyocytes induced by diabetes, and the mechanism is related to the
SIRT3 /NLRP3 signaling pathway.